Head To Head Top Stocks: American Renal Associates Holdings, Inc (NYSE:ARA), Macerich Company (The) (NYSE:MAC)

American Renal Associates Holdings, Inc (NYSE:ARA)

American Renal Associates Holdings, Inc (NYSE:ARA) closed at $7.15 on the last trading session with an increase of 1.56%, whereas, it previously closed at $7.04. The company has a market capitalization of $236.67 Million. The company traded shares of 84024 on the trading day while its three month average volume stands at 183.1 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of American Renal Associates Holdings, Inc (NYSE:ARA) produced diluted EPS of -0.54. The EPS estimate for next year as estimated by analysts is at 0.46 while EPS for next quarter is estimated at 0.08. Earnings per Share growth for this year is reported at -3.6, while the analysts estimated the EPS growth for next year at 0.46% and Earnings growth for next 5 years stands at 3% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -24.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of American Renal Associates Holdings, Inc (NYSE:ARA) is at 0 while the forward p/e is at 15.44. The P/S or Price to Sales ratio of American Renal Associates Holdings, Inc (NYSE:ARA) stands at 0.29 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 3.19. The quick ratio and the current ratio of American Renal Associates Holdings, Inc (NYSE:ARA) are reported at 1 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for American Renal Associates Holdings, Inc (NYSE:ARA) stands at -1.6, 24.3 and 19.1 respectively

The trailing twelve month Revenue of American Renal Associates Holdings, Inc (NYSE:ARA) is reported at 817.2 Million with income of -17200000. The outstanding shares of American Renal Associates Holdings, Inc (NYSE:ARA) are 33.1 Million. The institutional Ownership of the shares of 93.2 stands at 0.80%, this figure is increased 0.07 in the last six months. The insider ownership for the shares of American Renal Associates Holdings, Inc (NYSE:ARA) is ticked at 2.8%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for American Renal Associates Holdings, Inc (NYSE:ARA) is the Mean Target Price estimated by the analysts which stands at 7. The 52 week high of American Renal Associates Holdings, Inc (NYSE:ARA) is placed at 23.99 and 52 week low is standing at 5.48.

Performance wise the shares of American Renal Associates Holdings, Inc (NYSE:ARA) fell down -3.25% for the week, it also rise 5.93% for the monthly performance, while for the quarter it went down 0.28%. The shares decrease -41.82% for the half year and plummeted for the Year-To-Date performance. The shares of American Renal Associates Holdings, Inc (NYSE:ARA) shrinked -57.36% for the yearly performance.

Macerich Company (The) (NYSE:MAC)

Macerich Company (The) (NYSE:MAC) closed at $30.98 on the last trading session with an decrease of -0.35%, whereas, it previously closed at $31.09. The company has a market capitalization of $4.36 Billion. The company traded shares of 1.57 Million on the trading day while its three month average volume stands at 1.68 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Macerich Company (The) (NYSE:MAC) produced diluted EPS of 0.71. The EPS estimate for next year as estimated by analysts is at 0.46 while EPS for next quarter is estimated at 0.1. Earnings per Share growth for this year is reported at -62.9, while the analysts estimated the EPS growth for next year at 0.46% and Earnings growth for next 5 years stands at 0.21% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -14.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Macerich Company (The) (NYSE:MAC) is at 43.63 while the forward p/e is at 67.79. The P/S or Price to Sales ratio of Macerich Company (The) (NYSE:MAC) stands at 4.59 and Price to Book or P/B for the most recent quarter stands at 1.53. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Macerich Company (The) (NYSE:MAC) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Macerich Company (The) (NYSE:MAC) stands at 0.7, 2 and 0.3 respectively

The trailing twelve month Revenue of Macerich Company (The) (NYSE:MAC) is reported at 950.1 Million with income of 100.3 Million. The outstanding shares of Macerich Company (The) (NYSE:MAC) are 140.76 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 1.03 in the last six months. The insider ownership for the shares of Macerich Company (The) (NYSE:MAC) is ticked at 0.4%, the figure is rose 15.72% in the last six months.

Some other important financial aspects to be discussed here for Macerich Company (The) (NYSE:MAC) is the Mean Target Price estimated by the analysts which stands at 43.18. The 52 week high of Macerich Company (The) (NYSE:MAC) is placed at 59.34 and 52 week low is standing at 30.33.

Performance wise the shares of Macerich Company (The) (NYSE:MAC) fell down -3.97% for the week, it also fell -8.86% for the monthly performance, while for the quarter it went up -23.68%. The shares decrease -27.67% for the half year and plummeted for the Year-To-Date performance. The shares of Macerich Company (The) (NYSE:MAC) shrinked -47.62% for the yearly performance.